Investigation of the Serum Visfatin, Fetuin A and Eotaxin Levels in Patients with Type 2 Diabetes Mellitus

Basit Öğe Kaydı
dc.contributor.authorKaya, Hacer
dc.contributor.authorSermet, Abdurrahman
dc.contributor.authorTasdemir, Ezel
dc.contributor.authorPekkolay, Zafer
dc.date.accessioned2024-04-24T17:47:31Z
dc.date.available2024-04-24T17:47:31Z
dc.date.issued2017
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage113en_US
dc.identifier.issn1748-1708
dc.identifier.issn1748-1716
dc.identifier.startpage113en_US
dc.identifier.urihttps://hdl.handle.net/11468/22564
dc.identifier.volume221en_US
dc.identifier.wosWOS:000419806200209
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofActa Physiologica
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleInvestigation of the Serum Visfatin, Fetuin A and Eotaxin Levels in Patients with Type 2 Diabetes Mellitusen_US
dc.titleInvestigation of the Serum Visfatin, Fetuin A and Eotaxin Levels in Patients with Type 2 Diabetes Mellitus
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu

We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics.
To learn more, please read our privacy policy.

Customize